EICHORCondition: Ulcerative Colitis and Crohn's Disease · Sponsor: Takeda
Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.
The purpose of this study is to assess the long-term safety of vedolizumab versus other biologic agents in participants with Ulcerative Colitis (UC) or Crohn's Disease (CD).
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Inclusion Criteria: 1. Signed informed consent, by the participant or a legally acceptable representative. 2. Aged at least 18 years. 3. Initiating vedolizumab or another biologic agent for UC or CD. 4. Signed release form, by the participant or a legally acceptable representative, permitting abstraction of the participant's medical records at Baseline and during participation in the study. Exclusion Criteria: 1. The participant is enrolled in a clinical trial in which treatment for CD or UC is managed through a protocol. 2. Prior treatment with vedolizumab. 3. Any other reason that, in the Investigator's opinion, makes the participant unsuitable to participate in this study.
Reproduced word-for-word from the public registry record — the study team can answer questions about it.
| University of Alabama | Birmingham, Alabama, United States | — |
| University of South Alabama | Mobile, Alabama, United States | — |
| University of Arizona Medical Center | Tucson, Arizona, United States | — |
| Scripps Clinic | La Jolla, California, United States | — |
| Stanford University | Palo Alto, California, United States | — |
| South Bay Gastroenterology Medical Group | Torrance, California, United States | — |
| Gastroenterology Center of Connecticut P.C. | Hamden, Connecticut, United States | — |
| Middlesex Gastroenterology Associates, Llc | Middletown, Connecticut, United States | — |
| Gastroenterology Group of Naples | Naples, Florida, United States | — |
| Florida Hospital Orlando | Orlando, Florida, United States | — |
| Gulf Region Clinical Research Institute | Pensacola, Florida, United States | — |
| Emory University Hospital, the Emory Clinic | Atlanta, Georgia, United States | — |
+ 275 more locations — full list on the registry record.
This study lists sites in the areas below. Each link shows other recruiting studies near that city, from the public registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT02674308